QUEBEC CITY, June 16, 2015 /CNW Telbec/ - handyem Inc. and FlowMetric Diagnostics Inc. announce their partnership centralized around the incorporation of handyem's HPC-150 portable flow cytometer within FlowMetric Diagnostics' mobile point-of-care diagnostic laboratory, the Mo-POD™. This unprecedented model of mobile laboratory platform is presented at the BIO International Conference at the Pennsylvania Convention Center, Philadelphia from June 15th to 18th 2015. By virtue of this strategic collaboration, both handyem and FlowMetric Diagnostics intend to accelerate flow cytometry as a precise and low cost diagnostic platform to service North American and Global medical needs.
handyem's HPC-150 flow cytometer integrates a revolutionary optical fiber microfluidic technology. The result is a streamlined, powerful analytical tool providing 6 parameter cytometric analysis in a compact, rugged and highly portable unit. "We are proud to partner with a company that shares our vision to simplify and decentralize medical diagnostics by the means of flow cytometry" said Alain Chandonnet, president and CEO of handyem. "We are convinced that the Mo-POD™ is a step forward to extend flow cytometry's current boundaries bringing the analytical instrumentation as close to the patients and samples as possible, even in remote geographies."
FlowMetric Diagnostics has engineered a mobile laboratory platform providing comprehensive flow cytometry systems for remote flow cytometry capabilities. The company develops sensitive and inexpensive assays and is positioned to launch a platform of tests monitoring cell mediated immune responses that require only small volumes of capillary blood. The Mo-POD™ system coupled with handyem's HPC-150 flow cytometer represents a breakthrough approach to diagnostics, paving the way for inexpensive personalized medicine.
Ren Capocasale, Founder and CEO of FlowMetric Diagnostics said "We believe that this partnership between FlowMetric Diagnostics and handyem will shift the paradigm of what actionable personalized medicine is for individuals in need of sensitive and specific diagnostics. This landmark partnership will redefine the way diagnostics are performed around the world" said Chris Molineaux, President and CEO of Pennsylvania Biotechnology Association. "Strategically drawing on handyem's innovative portable flow cytometry technology and coupling this with FlowMetric Diagnostics' assay portfolio and mobile lab units, represents a powerful opportunity to transform patient services and pandemic responses. This is truly a mobile solution in global healthcare."
handyem Inc. offers novel portable and easy-to-use flow cytometers for faster access to precise characterization of cells and biological samples outside of the traditional core lab setting. Established in 2011, handyem is a private company based in Quebec City (Canada) with the mission to democratize cytometryTM. For more information visit www.handyem.com.
About FlowMetric Diagnostics
FlowMetric Diagnostics, an affiliate of FlowMetric Inc., based in Doylestown, PA and founded in December 2013, utilizes a flow cytometry-based platform to analyze cell-mediated immune responses. The company's proprietary assays require only small volumes of capillary blood, eliminating the need for venous blood draw. The technology can be readily adapted for infection screening and immune response evaluation through highly sensitive biomarker analysis. For more information, visit www.flowmetric.com and www.flowmetricdiagnostics.com.
SOURCE handyem Inc.
Image with caption: "handyem and FlowMetric Diagnostics (CNW Group/handyem Inc.)". Image available at: http://photos.newswire.ca/images/download/20150616_C8048_PHOTO_EN_18106.jpg
For further information: Lorena Ruelas, Marketing Specialist, handyem Inc., 240-2666 Boul. du Parc Technologique, Quebec, QC, G1P 4S6, Tel. 418-650-5999 Ext. 2117, email@example.com